#Netherlands #Clinical Trials #Amsterdam #myTomorrows #Scout Clinical

Enhancing Global Clinical Trials with myTomorrows and Scout Clinical

In an era where health technology is rapidly evolving, the significance of effective patient recruitment in clinical trials cannot be underestimated. On April 15, 2025, myTomorrows, a prominent health technology company, announced its strategic partnership with Scout Clinical, a leading provider in biopharmaceutical services and technology. This collaboration aims to modernize and streamline cross-border patient recruitment processes for clinical trials, enhancing access to treatments that may alter the course of patient lives.

Addressing the Challenges of Cross-Border Recruitment

The recruitment of patients from diverse geographical backgrounds is riddled with complexities. From regulatory differences and fragmented data systems to logistical concerns surrounding travel and accommodations, the process can be overwhelming for patients, families, and caregivers alike. When engaging participants in clinical trials, these hurdles often lead to prolonged recruitment timelines, escalating costs, and reduced patient diversity—all of which contribute to significant delays in offering potentially life-saving therapies.

Understanding these challenges, the partnership between myTomorrows and Scout Clinical seeks to alleviate the burdens typically associated with international clinical trials. They propose a comprehensive approach that integrates the initial identification of clinical trial options with personalized support services for patients and their families. With innovations in logistics and patient care, both companies are strategically positioned to enhance the experience of prospective trial participants.

A Seamless Patient Journey

At the heart of this collaboration is the goal to optimize the patient experience. MyTomorrows’ Patient Navigator team works diligently to assist patients in identifying suitable trial options and facilitate the pre-screening process. Meanwhile, Scout Clinical enhances this journey with critical support services. These include organizing travel arrangements, managing expense reimbursements, and providing pre-funded debit cards to cover out-of-pocket costs. Additionally, they ensure housing support is available, whether patients need temporary accommodation or extended stays, thereby easing the logistical burdens placed on families.

To further streamline the process, Scout also assists patients with visa applications and entry-exit procedures, directly addressing one of the most significant barriers faced by international trial participants. This collaborative effort constructs a clearer pathway for patients, making it easier for them to navigate the complexities of participating in clinical research across borders.

Leverage on Technology

The myTomorrows and Scout Clinical alliance harnesses advanced technology, including artificial intelligence, to transform the recruitment landscape. MyTomorrows employs a proprietary AI platform that can rapidly identify candidates for clinical trials, enabling physicians to reduce eligibility criteria checking time by an impressive 90% compared to traditional methods. This not only alleviates administrative burdens but also significantly bolsters the efficiency of the screening process.

On the other hand, Scout Clinical supports trial sites by diversifying patient enrollment pools and optimizing overall trial operations. Their combined efforts aim to ensure that researchers can meet their recruitment targets while continuing to comply with international data protection regulations.

A Game-Changer for Clinical Research

As the healthcare landscape becomes increasingly interconnected, initiatives that promote inclusivity and accessibility in clinical trials are more critical than ever. The partnership between myTomorrows and Scout Clinical addresses an urgent need within the industry: to break down geographical barriers and improve patient access to trial participation.

Dr. Michel van Harten, CEO of myTomorrows, articulated the essence of this collaboration by stating, “By removing barriers and overcoming the geographic silos of traditional trials, we provide every patient, regardless of location or personal circumstances, with a real opportunity to participate.” This sentiment resonates throughout the objectives of both organizations, as they work together to enhance the patient journey and accelerate clinical research.

Ultimately, the partnership symbolizes a significant advancement in global clinical research efforts, ensuring that patients from diverse backgrounds have greater access to groundbreaking treatments that could profoundly impact their health outcomes.